North America Capillary Blood Collection And Sampling Devices Market Analysis

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

North America Capillary Blood Collection And Sampling Devices Market Analysis

  • Healthcare
  • Upcoming Report
  • Jun 2024
  • North America
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Frequently Asked Questions

The market is segmented based on North America Capillary Blood Collection and Sampling Devices Market, By Product (Blood Sampling Devices, Capillary Blood Collection Devices, Rapid Test Cassette, Remote Capillary Blood Collection Device, and Wearable Capillary Blood Collection Device), Modality (Manual Sampling and Automated/Autoinjection Sampling), Mode of Administration (Puncture and Incision), Application (Cardiovascular Disease, Infection and Infectious Disease, Respiratory Diseases, Cancers, Rheumatoid Arthritis, and Others), Platform (Enzyme Immunoassay Platform (ELISA Platform), PCR Platform, Lateral Flow Immunoassay Platform, ELTABA Platform, and Others), Procedure (Conventional and Point of Care Testing), Age Group (Geriatrics, Infant, Pediatric, and Adult), Test Type (Whole Blood Test, Dried Blood Spot Tests, Plasma/Serum Protein Tests, Liver Panel/Liver Profile/Liver Function Tests, Comprehensive Metabolic Panel (CMP) Tests, and Others), Technology (Volumetric Absorptive Microsampling, Capillary Electrophoresis-Based Chemical Analysis, and Others), Material (Plastic, Glass, Stainless Steel, and Ceramic), End User (Laboratories and Home Care Setting), Distribution Channel (Direct Tender, Retail Sales, and Others) – Industry Trends and Forecast to 2031. .
The North America Capillary Blood Collection And Sampling Devices Market size was valued at USD 1.17 USD Billion in 2023.
The North America Capillary Blood Collection And Sampling Devices Market is projected to grow at a CAGR of 5.6% during the forecast period of 2024 to 2031.
The major players operating in the market include BD , TERUMO BCT, Fresenius Kabi AG , Grifols, S.A. , Nipro Europe Group Companies , Greiner Bio-One International GmbH , Quest Diagnostics ,orporated , Mitra Industries Private Limited , SARSTEDT AG & Co. KG , CML Biotech , Macopharma , Neomedic Limited , Haemonetics Corporation , ICU Medical, SB-KAWASUMI LABORATORIES, and Retractable Technologies, .
The market report covers data from the U.S., Canada and Mexico.